Filing Flows › Biolargo (BLGO) › R&D spending
Biolargo (BLGO) R&D spending by quarter
Biolargo's R&D spending was $1.1M in Q2 2026 (second quarter 2026), +20% from Q1 2026. Over the last 7 quarters it ranged from $535K (Q2 2025) to $1.1M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.1M | +20% | +103% |
| Q1 2026 | $907K | +38% | +15% |
| Q4 2025 | $659K | +7% | -16% |
| Q3 2025 | $615K | +15% | — |
| Q2 2025 | $535K | -32% | — |
| Q1 2025 | $791K | +0.9% | — |
| Q4 2024 | $784K | — | — |
Q2 2026 at a glance
Biolargo, Q2 2026: revenue $1.2M (-55% year over year), operating margin -298.7%, net loss $4.0M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biolargo's R&D spending?
Biolargo's R&D spending was $1.1M in Q2 2026 (second quarter 2026), +20% from Q1 2026.
How has Biolargo's R&D spending changed?
Over the last 7 quarters it ranged from $535K (Q2 2025) to $1.1M (Q2 2026).